We identified enterotoxigenic Bacteroides fragilis in stool specimens of patients with inflammatory bowel disease and other gastrointestinal disorders. The organism was detected in 11 (13.2%) of 83 patients with inflammatory bowel disease. Of 57 patients with active disease, 19.3% were toxin positive; none of those with inactive disease had specimens positive for enterotoxigenic Bacteroides fragilis gene sequences.
|Original language||English (US)|
|Number of pages||4|
|Journal||Emerging Infectious Diseases|
|State||Published - Mar 2000|
ASJC Scopus subject areas
- Microbiology (medical)